TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10021716

Group type: EXPERIMENTAL
Intervention: Porcine surfactant prophylaxis (200 mg/kg endotracheally)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Routine assistance (Control)
Number of subjects: 53
Study: 8498878

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Desipramine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 3691610

Group type: EXPERIMENTAL
Intervention: 60 mg trimetazidine (single dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20 mg trimetazidine (chronic administration, three times a day)
Number of subjects: 0
Study: 29861018

Group type: EXPERIMENTAL
Intervention: Apligraf
Number of subjects: 0

Group type: COMPARATOR
Intervention: TheraSkin
Number of subjects: 0
Study: 27468128

Group type: EXPERIMENTAL
Intervention: High-fructose diet (HFrD) (+3.5 g fructose/kg fat-free mass per day) for 7 days
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-fructose diet (HFrD)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: In vitro experiments in human myotubes
Number of subjects: 10
Study: 25910661

Group type: EXPERIMENTAL
Intervention: Left lateral position during colonoscope withdrawal on the right side of the colon
Number of subjects: 130

Group type: COMPARATOR
Intervention: Supine position during colonoscope withdrawal on the left side of the colon
Number of subjects: 130
Study: 24296342

Group type: EXPERIMENTAL
Intervention: Facial exercises (daily training for 7 weeks)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 18
Study: 20650362

Group type: EXPERIMENTAL
Intervention: Short door-to-balloon time (DBT) (<= 90 min)
Number of subjects: 4548

Group type: EXPERIMENTAL
Intervention: Short DBT (<= 90 min) in early presentation
Number of subjects: 4548

Group type: EXPERIMENTAL
Intervention: Short DBT (<= 90 min) in later presentation
Number of subjects: 4548

Group type: EXPERIMENTAL
Intervention: Short DBT (<= 90 min) in high-risk patients
Number of subjects: 4548

Group type: EXPERIMENTAL
Intervention: Short DBT (<= 90 min) in low-risk patients
Number of subjects: 4548

Group type: EXPERIMENTAL
Intervention: Short DBT (<= 90 min) in high-risk patients with early presentation
Number of subjects: 4548

Group type: EXPERIMENTAL
Intervention: Short DBT (<= 90 min) in low-risk patients with early presentation
Number of subjects: 4548
Study: 19004053

Group type: EXPERIMENTAL
Intervention: Etanercept (TNF-alpha antagonist)
Number of subjects: 40
Study: 16648318

Group type: EXPERIMENTAL
Intervention: Olanzapine (5‐15 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 60
Study: 12511713

Group type: COMPARATOR
Intervention: Saline inhalation
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: HDM allergen inhalation
Number of subjects: 18
Study: 10368793

Group type: EXPERIMENTAL
Intervention: Nasal salmon calcitonin (200 IU daily for 2 months, followed by a 2-month pause, repeated for 3 cycles) and 500 mg calcium daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Calcium and vitamin D only (control group)
Number of subjects: 24
Study: 8899498

Group type: EXPERIMENTAL
Intervention: HBsAg positive Down syndrome patients
Number of subjects: 57

Group type: COMPARATOR
Intervention: HBsAg negative Down syndrome patients
Number of subjects: 57

Group type: COMPARATOR
Intervention: Mentally retarded patients without Down syndrome
Number of subjects: 57
Study: 2053087

Group type: EXPERIMENTAL
Intervention: Tenoxicam administered at 8 am or 12 pm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tenoxicam administered at midday
Number of subjects: 0
Study: 6754331

Group type: EXPERIMENTAL
Intervention: 50 g palatinite
Number of subjects: 24

Group type: COMPARATOR
Intervention: 50 g glucose
Number of subjects: 24
Study: 31071535

Group type: EXPERIMENTAL
Intervention: Intramuscular hypertonic saline injection to the vastus medialis
Number of subjects: 13

Group type: COMPARATOR
Intervention: Isotonic saline injection (sham)
Number of subjects: 13
Study: 30217378

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 1834

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1834
Study: 26890031

Group type: EXPERIMENTAL
Intervention: 100,000 IU vitamin D bimonthly
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 24184512

Group type: EXPERIMENTAL
Intervention: Exercise (30 minutes, moderate exercise on cycling ergometer)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Artificial Gravity (AG) exposure (+2Gz for 30 minutes)
Number of subjects: 16
Study: 22087795

Group type: EXPERIMENTAL
Intervention: Brown seaweed (Ascophyllum nodosum and Fucus vesiculosus) 500 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 19063686

Group type: EXPERIMENTAL
Intervention: PTH(1-34) treatment for 1 year
Number of subjects: 1

Group type: COMPARATOR
Intervention: Control group (not on PTH)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: PTH(1-34) treatment
Number of subjects: 1
Study: 16479532

Group type: EXPERIMENTAL
Intervention: Three-dimensional localized spectroscopic imaging sequence
Number of subjects: 5
Study: 12631508

Group type: EXPERIMENTAL
Intervention: FFP fruit and vegetable intake
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: FFP consumption of high‐fat foods
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Shared meals with FFP
Number of subjects: 282
Study: 10833696

Group type: EXPERIMENTAL
Intervention: Telephone therapy (10 sessions of 30 minutes each)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Assessment-only control group
Number of subjects: 53
Study: 10167365

Group type: EXPERIMENTAL
Intervention: School-wide media-marketing campaign, school-wide meal and snack modification, classroom workshops, parental involvement
Number of subjects: 2339

Group type: EXPERIMENTAL
Intervention: Media-marketing activities
Number of subjects: 2339

Group type: EXPERIMENTAL
Intervention: Focus groups for program development
Number of subjects: 2339
Study: 1529682

Group type: EXPERIMENTAL
Intervention: Autologous blood transfusion (2-3 units deposited preoperatively, intraoperative blood salvage used)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Autologous blood transfusion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Homologous blood transfusion
Number of subjects: 30
Study: 3888336

Group type: EXPERIMENTAL
Intervention: Node sampling
Number of subjects: 417

Group type: COMPARATOR
Intervention: Axillary clearance
Number of subjects: 417

Group type: COMPARATOR
Intervention: No further surgery after node sampling
Number of subjects: 417
Study: 30801508

Group type: EXPERIMENTAL
Intervention: Male protagonist in 'first solo laparoscopic surgery' scenario
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Male responses rating female performance
Number of subjects: 134

Group type: COMPARATOR
Intervention: Responses to clinical performance rating and selection of action
Number of subjects: 134
Study: 28554911

Group type: EXPERIMENTAL
Intervention: Question Prompt List (QPL) intervention
Number of subjects: 480

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 480
Study: 26307511

Group type: EXPERIMENTAL
Intervention: 1-Hz rTMS at 90% of resting motor threshold to PMC + M1 (600 pulses each, 1200 total)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 1-Hz rTMS at 90% of resting motor threshold to M1 (1200 pulses)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 1-Hz rTMS at 90% of resting motor threshold to PMC (1200 pulses)
Number of subjects: 10
Study: 22163281

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation (100, 400, 4000 µg per day) for 6 months
Number of subjects: 0
Study: 19459233

Group type: EXPERIMENTAL
Intervention: Higher support (phone coaching plus monthly exercise support group)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Lower support (phone coaching only)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Awareness (informational brochure, no coaching)
Number of subjects: 92
Study: 16758422

Group type: EXPERIMENTAL
Intervention: Discontinuation of primary prophylaxis
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Discontinuation of secondary prophylaxis
Number of subjects: 438
Study: 15353377

Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine individual therapy
Number of subjects: 0
Study: 10665618

Group type: EXPERIMENTAL
Intervention: Physostigmine (24 mg/d and 30 mg/d)
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Physostigmine
Number of subjects: 850

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 850
Study: 9074573

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 53

Group type: COMPARATOR
Intervention: Diazepam (active placebo)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Saline (inert placebo)
Number of subjects: 53
Study: 8459989

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 0
Study: 3093918

Group type: EXPERIMENTAL
Intervention: Transfer factor from leukocytes of random donors
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Transfer factor from leukocytes of family members
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Transfer factor therapy
Number of subjects: 105
Study: 31714266

Group type: EXPERIMENTAL
Intervention: Animation education program
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional face-to-face education (Control)
Number of subjects: 80
Study: 30486630

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy with Inj. Cisplatin 100 mg/m2 for three-weekly and EBRT with 60 Co/LINAC and photon radiation of 70 Gy in 35 fractions for 7 weeks.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Chemo boost with Inj. Cisplatin 6 mg/m2 on last 15 fractions of treatment and EBRT with 60 Co/LINAC photon radiation of 70 Gy in 35 fractions for 7 weeks.
Number of subjects: 64
Study: 26947142

Group type: EXPERIMENTAL
Intervention: External Focus (EF)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Internal Focus (IF)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Both EF and IF
Number of subjects: 9
Study: 23768683

Group type: EXPERIMENTAL
Intervention: Sertraline treatment for 12 weeks
Number of subjects: 126
Study: 22169050

Group type: EXPERIMENTAL
Intervention: Aspirin (1000 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acetaminophen (300 mg) with codeine (30 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20377504

Group type: EXPERIMENTAL
Intervention: Ligasure tonsillectomy
Number of subjects: 150

Group type: COMPARATOR
Intervention: Bipolar diathermy scissors tonsillectomy
Number of subjects: 150
Study: 18336971

Group type: EXPERIMENTAL
Intervention: Bony intramaxillary sinus septa present
Number of subjects: 75

Group type: COMPARATOR
Intervention: No bony septa or septa < 4mm
Number of subjects: 75
Study: 17065897

Group type: EXPERIMENTAL
Intervention: Remifentanil (0.1 microg x kg x min)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Parecoxib (40 mg) administered preventively with electrical stimulation
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Parecoxib (40 mg) administered in parallel to remifentanil infusion
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 15
Study: 14513000

Group type: EXPERIMENTAL
Intervention: Computer Assisted Learning (CAL) programme
Number of subjects: 61

Group type: COMPARATOR
Intervention: Traditional small group tutorials
Number of subjects: 61
Study: 11134918

Group type: EXPERIMENTAL
Intervention: Counselling (CBT or psychodynamic approach) in addition to usual GP treatment
Number of subjects: 181

Group type: COMPARATOR
Intervention: Usual GP treatment (Control)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Counselling (CBT or psychodynamic approach)
Number of subjects: 181
Study: 9362434

Group type: EXPERIMENTAL
Intervention: Pamidronate 90 mg as a 2-hour infusion monthly for 2 years
Number of subjects: 751

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 751
Study: 1397827

Group type: EXPERIMENTAL
Intervention: Monthly journal club sessions with two didactic sessions before the club started.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group of pediatric residents at another institution.
Number of subjects: 0
Study: 4029557

Group type: EXPERIMENTAL
Intervention: Gastric distention (0, 250, 500, or 750 ml of air for 15 min)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Gastric distention
Number of subjects: 33
Study: 31405697

Group type: EXPERIMENTAL
Intervention: Diabetic Yoga Protocol (DYP) for 3 months
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (non‐practising)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Diabetic Yoga Protocol (DYP)
Number of subjects: 37
Study: 30400122

Group type: EXPERIMENTAL
Intervention: Meditation (45 minutes daily for 6 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard medical treatment
Number of subjects: 60
Study: 27835765

Group type: EXPERIMENTAL
Intervention: Insulin glargine 300U/mL (Gla-300)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Insulin glargine 100U/mL (Gla-100)
Number of subjects: 243
Study: 24934333

Group type: EXPERIMENTAL
Intervention: Extinction during reconsolidation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard extinction
Number of subjects: 0
Study: 23193743

Group type: EXPERIMENTAL
Intervention: Pregabalin 75 mg
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 20156072

Group type: EXPERIMENTAL
Intervention: Low-fat diet plus weight-reducing drugs when necessary
Number of subjects: 107
Study: 17934150

Group type: EXPERIMENTAL
Intervention: Prandial premixed therapy (PPT) - lispro mix 50/50 (50% insulin lispro protamine suspension and 50% lispro); n = 187
Number of subjects: 374

Group type: COMPARATOR
Intervention: Basal/bolus therapy (BBT) - glargine at bedtime plus mealtime lispro; n = 187
Number of subjects: 374
Study: 16463828

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (2 min proximal temporary artery occlusion followed by 30 min reperfusion)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 12
Study: 12203667

Group type: EXPERIMENTAL
Intervention: 10,000 lux bright white light for 30 min between 6 and 9 AM
Number of subjects: 13

Group type: COMPARATOR
Intervention: Dim red (placebo) light at a comparable time
Number of subjects: 13
Study: 10510028

Group type: EXPERIMENTAL
Intervention: Tilting disc valve (Medtronic Hall)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bileaflet valve (St. Jude Medical)
Number of subjects: 0
Study: 8536749

Group type: EXPERIMENTAL
Intervention: Colour Doppler flow imaging ultrasonography (CDFI)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Venography
Number of subjects: 82
Study: 1960381

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0
Study: 6890839

Group type: EXPERIMENTAL
Intervention: Sorbidilat retard forte
Number of subjects: 6

Group type: COMPARATOR
Intervention: Standard preparation (40 mg isosorbide dinitrate as retard formulation)
Number of subjects: 6
Study: 31388683

Group type: EXPERIMENTAL
Intervention: rhBNP
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study: 28828764

Group type: EXPERIMENTAL
Intervention: Topical insulin 0.5 units per drop 4 times per day (QID)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Topical insulin 1 unit per drop 4 times per day (QID)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Topical insulin 2 units per drop 4 times per day (QID)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (DNS)
Number of subjects: 32
Study: 26998724

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ) 150 mg daily for 8 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 23787192

Group type: EXPERIMENTAL
Intervention: En-masse retraction with mini-implants
Number of subjects: 80

Group type: COMPARATOR
Intervention: Two-step retraction with transpalatal arches (TPAs)
Number of subjects: 80
Study: 21934167

Group type: EXPERIMENTAL
Intervention: Brief motivational intervention (BMI)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Education-only (EO) condition
Number of subjects: 70
Study: 19220273

Group type: EXPERIMENTAL
Intervention: Zerostat‐V (ZS)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nebuchamber (NC)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Aerochamber Max (AC)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Evohaler (EH)
Number of subjects: 18
Study: 18074699

Group type: EXPERIMENTAL
Intervention: Initial payoffs for tasks varied between participants
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Previous strategy based on initial payoffs
Number of subjects: 60
Study: 15284602

Group type: EXPERIMENTAL
Intervention: Repetitive nerve stimulation (RNS) with exercise after 20 seconds of maximal exercise at 1-minute intervals up to 3 minutes.
Number of subjects: 89

Group type: COMPARATOR
Intervention: Conventional 3‐Hz RNS at rest.
Number of subjects: 89
Study: 11981084

Group type: EXPERIMENTAL
Intervention: Folic acid 15 mg/day orally
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Methylcobalamin 500 mg intravenously after each HD, in addition to folic acid
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Vitamin B(6) 60 mg/day orally, in addition to folic acid and methylcobalamin
Number of subjects: 21

Group type: COMPARATOR
Intervention: Methylcobalamin alone (HD control group)
Number of subjects: 21
Study: 9842841

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 19

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 19
Study: 8575497

Group type: EXPERIMENTAL
Intervention: 10 mg finasteride for 1 year, then 5 mg finasteride for 4 years
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: 5 mg finasteride for the entire 5 years
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Finasteride treatment
Number of subjects: 190
Study: 2759398

Group type: EXPERIMENTAL
Intervention: Forceps biopsy
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Metal needle biopsy (21 gauge 13-mm long metal needles)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Plastic needle biopsy (18 gauge 20-mm long plastic needles)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Salvage cytology
Number of subjects: 23
Study: 331877

Group type: EXPERIMENTAL
Intervention: Fronto-frontal ECT (FF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Temporo-parietal ECT (TP)
Number of subjects: 0
Study: 30916641

Group type: EXPERIMENTAL
Intervention: Three-part intervention package including a triage tool, a study-designed web page, and a brief one-to-one session based on motivational interviewing for high-risk patients.
Number of subjects: 6

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 6
Study: 28107680

Group type: EXPERIMENTAL
Intervention: Buprenorphine Treatment
Number of subjects: 211

Group type: COMPARATOR
Intervention: Counseling Only
Number of subjects: 211
Study: 25646328

Group type: EXPERIMENTAL
Intervention: PNPLA3 G-allele carriers
Number of subjects: 200
Study: 24238896

Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 339

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 339
Study: 21658971

Group type: EXPERIMENTAL
Intervention: Thought suppression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unfocused attention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Focused attention (mindfulness)
Number of subjects: 0
Study: 19478295

Group type: EXPERIMENTAL
Intervention: 6-month naltrexone implant
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual aftercare
Number of subjects: 56
Study: 17092597

Group type: EXPERIMENTAL
Intervention: Insulin aspart
Number of subjects: 18

Group type: COMPARATOR
Intervention: Unmodified human insulin
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Insulin aspart and unmodified human insulin
Number of subjects: 18
Study: 14660479

Group type: EXPERIMENTAL
Intervention: Skin surface cooling (SSC)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control conditions
Number of subjects: 8
Study: 11466160

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 6
Study: 9684717

Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Upright position
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Supine position (1 week after implantation)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Upright position (1 week after implantation)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Supine position (3 months after implantation)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Upright position (3 months after implantation)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both body positions
Number of subjects: 52
Study: 7889225

Group type: EXPERIMENTAL
Intervention: AB/BA design
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-stage procedure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Analysis of covariance
Number of subjects: 0
Study: 3126306

Group type: EXPERIMENTAL
Intervention: Praziquantel 20-40 mg kg‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Praziquantel 30-40 mg kg‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low doses of praziquantel
Number of subjects: 0
Study: 30412630

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (enoxaparin)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Control (not receiving low molecular weight heparin)
Number of subjects: 242
Study: 27291074

Group type: EXPERIMENTAL
Intervention: Highest quartile of occupational physical activity (OPA)
Number of subjects: 385
Study: 24895813

Group type: EXPERIMENTAL
Intervention: Mononuclear cells (MNCs)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: CD34+ cells
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control
Number of subjects: 4
Study: 22440072

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Cognitive Therapy (MBCT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 52
Study: 20536800

Group type: EXPERIMENTAL
Intervention: Heat therapy (n = 31)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cold therapy (n = 29)
Number of subjects: 60
Study: 18414370

Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 96

Group type: COMPARATOR
Intervention: Bupivacaine
Number of subjects: 96